PDF herunterladen
Drug Res (Stuttg) 2020; 70(12): 552-562
DOI: 10.1055/a-1167-0529
Original Article

Development and Validation of a Stability Indicating LC-MS/MS Method for the Determination of Clenbuterol HCl

Krunal J. Prajapati
1   Department of Pharmaceutical Analysis, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
,
Charmy Kothari
1   Department of Pharmaceutical Analysis, Institute of Pharmacy, Nirma University, Ahmedabad, Gujarat, India
› Institutsangaben Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Clenbuterol hydrochloride (CLT), β2 adrenergic agonist is used as a bronchodilator in the therapeutic treatment of asthma. It is important to know the stability behaviour of the drug in different degradation conditions as per ICH Q1A (R2) guidelines for safety and efficacy purpose. The main objective of the study is to develop and validate stability indicating LC-MS/MS method for the determination of Clenbuterol HCl. The separation was achieved using Phenomenex Gemini NX C18 (250*4.6 mm, 5 μ) column and the mobile phase consisting of ammonium acetate buffer (5 mM), 0.15% triethylamine (TEA), pH 7.5 with acetic acid: methanol (70:30, v/v) at flow rate 1 ml/min. The detection was done using PDA detector at 245 nm. The validation was performed as per ICH Q2 (R1) guideline. The drug was subjected to stress degradation conditions as per ICH Q1A (R2) guidelines. The significant degradation was observed in acidic (8.78%) and sunlight (liquid) (9%) condition while no degradation was observed in neutral, basic, oxidation and thermal condition. The drug and its degradation products were characterized using LC-MS/MS and the proposed degradation mechanism was communicated. The developed method was found to be stability-indicating, simple, specific, selective, sensitive, linear, accurate, robust and precise and used as a routine analysis in quality control laboratory.

Key words

anti-asthma/COPD drugs - chemistry - drug research

Supporting Information



Publikationsverlauf

Eingereicht: 16. März 2020

Angenommen: 13. April 2020

Artikel online veröffentlicht:
16. September 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Chang LY, Chou SS, Hwang DF. High performance liquid chromatography to determine animal drug clenbuterol in pork, beef and hog liver. Journal of Food and Drug Analysis 2005; 13: 163-167
    PubMedGoogle Scholar
  • 2 Morales-Trejo F, Leon S, Escobar-Medina A. et al. Application of high-performance liquid chromatography-UV detection to quantification of clenbuterol in bovine liver samples. Journal of Food and Drug Analysis 2013; 21: 414-420
    CrossrefPubMedGoogle Scholar
  • 3 Rosales-Conrado N, Leon-Gonzalez M, Polo-Diez L. Development and validation of analytical method for clenbuterol chiral determination in animal feed by direct liquid chromatography. Food Analytical. Methods 2015; 8: 2647-2659
    PubMedGoogle Scholar
  • 4 Parr MK, Opfermann G, Schänzer W. Analytical methods for the detection of clenbuterol. Bioanalysis 2009; 1: 437-450
    CrossrefPubMedGoogle Scholar
  • 5 Masci G, Casati G, Crescenzi V. Synthesis and LC characterization of clenbuterol molecularly imprinted polymers. Journal of Pharmaceutical and Biomedical Analysis 2001; 25: 211-217
    CrossrefPubMedGoogle Scholar
  • 6 British Pharmacopoeia. British Pharmacopoeia Commission, London, 2018
    PubMed
  • 7 United states Pharmacopoeia USP 42. The United states Pharmacopeial Commission, USA, 2018
    PubMed
  • 8 Liu B, Yan H, Qiao F. et al. Determination of clenbuterol in porcine tissues using solid-phase extraction combined with ultrasound-assisted dispersive liquid-liquid microextraction and HPLC-UV detection. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2011; 879: 90-94
    CrossrefPubMedGoogle Scholar
  • 9 Geng Y, Zhang M, Yuan W. et al. Modified dispersive liquid-liquid microextraction followed by high-performance liquid chromatography for the determination of clenbuterol in swine urine. Food Additives and Contamination Part a-Chemistry Analysis Control Exposure & Risk Assessment 2011; 28: 1006-1012
    PubMedGoogle Scholar
  • 10 Li X, Zhou M, Turson M. et al. Preparation of clenbuterol imprinted monolithic polymer with hydrophilic outer layers by reversible addition-fragmentation chain transfer radical polymerization and its application in the clenbuterol determination from human serum by on-line solid-phase. Analyst 2013; 138: 3066-3074
    CrossrefPubMedGoogle Scholar
  • 11 Qiao F, Du J. Rapid screening of clenbuterol hydrochloride in chicken samples by molecularly imprinted matrix solid-phase dispersion coupled with liquid chromatography. Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences 2013; 923–924: 136-140
    CrossrefPubMedGoogle Scholar
  • 12 Mokhtari B, Pourabdollah K. Chromatographic separation of clenbuterol by bonded phases bearing nano-baskets of p-tert-calix [4]-1,2-crown-3, -crown-4, -crown-5 and -crown-6. Journal of Scientific Food Agriculture 2012; 92: 2679-2688
    CrossrefPubMedGoogle Scholar
  • 13 Risticevic S, Lord H, Gorecki T. et al. Protocol for solid-phase microextraction method development. Nature Protocols 2010; 5: 122-139
    CrossrefPubMedGoogle Scholar
  • 14 Berggren C, Bayoudh S, Sherrington D. et al. Use of molecularly imprinted solid-phase extraction for the selective clean-up of clenbuterol from calf urine. Journal of Chromatography A 2000; 889: 105-110
    CrossrefPubMedGoogle Scholar
  • 15 Zhang XZ, Gan YR, Zhao FN. Determination of clenbuterol in pig liver by high-performance liquid chromatography with a coulometric electrode array system. Analytica Chimica Acta 2003; 489: 95-101
    CrossrefPubMedGoogle Scholar
  • 16 Ozkan Y, Ozkan S, Aboul-Enein H. Determination of clenbuterol HCI in human serum, pharmaceuticals, and in drug dissolution studies by RP-HPLC. Journal of Liquid Chromatography and Related Technologies 2001; 24: 679-691
    CrossrefPubMedGoogle Scholar
  • 17 Wen Y, Wang Y, Feng YQ. Extraction of clenbuterol from urine using hydroxylated poly (gycidyl methacrylate-co-ethylene dimethacrylate) monolith microextraction followed by high-performance liquid chromatography determination. Journal of Separation Science 2007; 30: 2874-2880
    CrossrefPubMedGoogle Scholar
  • 18 Aresta A, Calvano C, Palmisano F. et al. Determination of clenbuterol in human urine and serum by solid-phase microextraction coupled to liquid chromatography. Journal of Pharmaceutical and Biomedical Anaysis 2008; 47: 641-645
    CrossrefPubMedGoogle Scholar
  • 19 Brambilla G, Fiori M, Rizzo B. et al. Use of molecularly imprinted polymers in the solid-phase extraction of clenbuterol from animal feeds and biological matrices. Journal of Chromatography B Biomedical Sciences and Applications 2001; 759: 27-32
    CrossrefPubMedGoogle Scholar
  • 20 Song Y, Wang D, Hu Y. et al. Direct separation and quantitative determination of clenbuterol enantiomers by high performance liquid chromatography using an amide type chiral stationary phase. Journal of Pharmaceutical and Biomedical Analysis 2003; 31: 311-319
    CrossrefPubMedGoogle Scholar
  • 21 ICH. Stability Testing of New Drug Substances and Products. International Conference on Harmonization, Q1(A) R2, 2003
    PubMed
  • 22 ICH. Validation of Analytical Procedures: Text and Methodology, Q2 (R1), 2005
    PubMed
  • 23 Material Safety Data Sheet [Internet], Santa Cruz: Santa Cruz Biotechnology, Inc., 2010. Available from: http://www.datasheets.scbt.com/sc-205635
    PubMed
  • 24 Montesissa C, Anfossi P, Biancotto G. et al. Invitro metabolism of clenbuterol and brombuterol by pig liver microsomes. XENOBIOTICA 1998; 28: 1049-1060
    CrossrefPubMedGoogle Scholar
  • 25 Doerge DR. Analysis of clenbuterol in human plasma using liquid chromatography atmospheric pressure chemical-ionization mass spectrometry. Rapid Communications in Mass Spectrometry 1993; 7: 462-464
    CrossrefPubMedGoogle Scholar
  • 26 Guan F, Uboh CE, Soma LR. et al. Quantification of clenbuterol in quine plasma, urine and tissue by liquid chromatography couple on-line with quadrupole time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry 2002; 16: 1642-1651
    CrossrefPubMedGoogle Scholar
  • 27 Thummar M, Patel PN, Petkar A. et al. Identification and degradation products of saquinavir mesylate by UHPLC-ESI-Q-TOF-MS/MS and its application to quality control. Rapid Communications in Mass Spectrometry 2017; 31: 771-781
    CrossrefPubMedGoogle Scholar
  • 28 Thummar M, Patel PN, Gananadhamu S. et al. Stability indicating assay method for acotiamide: separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process related impurity by UHPLC-ESI-QTOF-MS/MS. Rapid Communications in Mass Spectrometry 2017; 31: 1813-1824
    CrossrefPubMedGoogle Scholar
  • 29 Pandeti S, Rout TK, Narender T. et al. Identification of stress degradation products of Iloperidone using liquid chromatography coupled with Orbitrap mass spectrometer. Rapid Communications in Mass Spectrometry 2017; 31: 1324-1332
    CrossrefPubMedGoogle Scholar
  • 30 Singh S, Junwal M, Modhe G. et al. Forced degradation study to assess the stability of the drugs and products. Trends in Analytical Chemistry 2013; 49: 71-88
    CrossrefPubMedGoogle Scholar
  • 31 Prajapati KJ, Kothari CS. First report on clorprenaline HCl degradation products: Identification and characterization by LC-MS/MS. Journal of the Iranain Chemical Society 2020; 17: 1027-1039
    CrossrefPubMedGoogle Scholar